Related references
Note: Only part of the references are listed.Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis
Yohei Ichimura et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2014)
Impaired In Vivo Neovascularization Capacity of Endothelial Progenitor Cells in Patients With Systemic Sclerosis
Masataka Kuwana et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis
Shinji Noda et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2013)
Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis
Shinji Noda et al.
RHEUMATOLOGY (2013)
Quantification of circulating endothelial progenitor cells in systemic sclerosis: a direct comparison of protocols
Masataka Kuwana et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis
Shinji Noda et al.
PLOS ONE (2012)
Angiogenesis and Vasculopathy in Systemic Sclerosis: Evolving Concepts
Bradley J. Rabquer et al.
CURRENT RHEUMATOLOGY REPORTS (2012)
CCN1/CYR61: the very model of a modern matricellular protein
Lester F. Lau
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Angiopoietins-1 and-2 are differentially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease
Malgorzata Michalska-Jakubus et al.
RHEUMATOLOGY (2011)
Endothelial Fli1 Deficiency Impairs Vascular Homeostasis A Role in Scleroderma Vasculopathy
Yoshihide Asano et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis
Yoshihide Asano et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2010)
Future treatments in systemic sclerosis
Yoshihide Asano
JOURNAL OF DERMATOLOGY (2010)
Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosis
Yukie Yamaguchi et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Transcription Factor Fli1 Regulates Collagen Fibrillogenesis in Mouse Skin
Yoshihide Asano et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
CD19 regulates skin and lung fibrosis via toll-like receptor signaling in a model of bleomycin-induced scleroderma
Ayumi Yoshizaki et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?
Jo N. Fleming et al.
PLOS ONE (2008)
Transforming growth factor-β regulates DNA binding activity of transcription factor fli1 by p300/CREB-binding protein-associated factor-dependent acetylation
Yoshihide Asano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The angiogenic factor CCN1 promotes adhesion and migration of circulating CD34+ progenitor cells:: potential role in angiogenesis and endothelial regeneration
Karsten Grote et al.
BLOOD (2007)
Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts
Youngqing Wang et al.
ARTHRITIS AND RHEUMATISM (2006)
Defective vasculogenesis in systemic sclerosis
M Kuwana et al.
LANCET (2004)
Identification of a novel integrin αvβ3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells
NY Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin
M Kubo et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
CYR61 (CCN1) is essential for placental development and vascular integrity
FE Mo et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins αvβ3 and α6β1 in human umbilical vein endothelial cells
SJ Leu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers
O Distler et al.
ARTHRITIS RESEARCH (2002)
The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts
CC Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor
DD Spyropoulos et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
